| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/20/2023 | MAXCYTE, INC. | MXCT | Grant | Stock Option (right to buy) | 40k | $4.19 | $167.6k | | 03/20/2023 |
| 06/29/2022 | MAXCYTE, INC. | MXCT | Grant | Stock Option (right to buy) | 26.9k | $4.82 | $129.7k | | 06/29/2022 |
| 06/15/2022 | ALX ONCOLOGY HOLDINGS INC | ALXO | Grant | Stock Option (right to buy) | 12k | $6.67 | $80.1k | | 06/15/2022 |
| 08/09/2021 | MAXCYTE, INC. | MXCT | Grant | Stock Option (right to buy) | 10k | $16.63 | $166.3k | | 08/09/2021 |
| 06/11/2021 | ALX ONCOLOGY HOLDINGS INC | ALXO | Grant | Stock Option (right to buy) | 12k | $59.66 | $716.2k | | 06/11/2021 |
| 07/21/2020 | ALX ONCOLOGY HOLDINGS INC | ALXO | Purchase | Common Stock | 3k | $19.00 | $57k | | 07/21/2020 |
| 06/23/2020 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 30k | $25.64 | $769.2k | | 06/23/2020 |
| 04/08/2020 | Aravive, Inc. | ARAV | Disposition | Common Stock | 42.8k | $0.00 | $0 | | 04/08/2020 |
| 01/09/2020 | Aravive, Inc. | ARAV | Grant | Stock Options | 143k | $13.77 | $2M | | 01/09/2020 |
| 01/09/2020 | Aravive, Inc. | ARAV | Grant | Common Stock | 57k | $0.00 | $0 | | 01/09/2020 |
| 08/15/2019 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 33.8k | $13.41 | $452.6k | | 08/15/2019 |
| 05/01/2019 | Adverum Biotechnologies, Inc. | ADVM | Grant | Stock Option (Right to Buy) | 70k | $6.48 | $453.6k | | 05/01/2019 |
| 03/25/2019 | Arcus Biosciences, Inc. | RCUS | Grant | Stock Option (right to buy) | 400k | $11.23 | $4.5M | | 03/25/2019 |